Triptorelin 11.25 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Triptorelin 11.25 mg, covering 2020-12-09 to 2020-12-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients. [Phase 4]